Blutribe Wednesday, 05/29/19 10:47:49 AM Re: wesley_ post# 2338 Post # of 2361 GENE .69 , 2nd IPO was recently priced at .80..so bargain price here : Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company. GTG offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company’s lead products GeneType for Breast Cancer and ‘GeneType for Colorectal Cancer’ are clinically validated risk assessment tests for non-hereditary breast cancer and are first in class. Genetic Technologies is developing a pipeline of risk assessment products. Buy OVERSOLD, sell OVERBOUGHT...Deep Pockets, so when I begin buying, watch out above! TECHNICAL and FUNDAMENTAL trader..